Flora Zagouri

10.2k total citations
301 papers, 4.0k citations indexed

About

Flora Zagouri is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Flora Zagouri has authored 301 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Oncology, 95 papers in Cancer Research and 72 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Flora Zagouri's work include Breast Cancer Treatment Studies (55 papers), Breast Lesions and Carcinomas (35 papers) and Ovarian cancer diagnosis and treatment (32 papers). Flora Zagouri is often cited by papers focused on Breast Cancer Treatment Studies (55 papers), Breast Lesions and Carcinomas (35 papers) and Ovarian cancer diagnosis and treatment (32 papers). Flora Zagouri collaborates with scholars based in Greece, United States and Belgium. Flora Zagouri's co-authors include Meletios Α. Dimopoulos, Theodoros Ν. Sergentanis, Dimosthenis Chrysikos, George Zografos, Rupert Bartsch, Christos Papadimitriou, Michalis Liontos, Konstantinos Koutsoukos, Αngeliki Andrikopoulou and Θεοδώρα Ψαλτοπούλου and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Flora Zagouri

277 papers receiving 3.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Flora Zagouri	1.7k	1.2k	873	718	508	301	4.0k
Dorothea Nagel	1.2k 0.7×	1.2k 1.1×	974 1.1×	568 0.8×	349 0.7×	86	3.9k
Sun‐Young Kong	1.3k 0.8×	1.4k 1.2×	683 0.8×	498 0.7×	416 0.8×	204	3.7k
Anthony M. Magliocco	1.8k 1.0×	1.3k 1.2×	853 1.0×	1.1k 1.5×	407 0.8×	136	4.2k
Saverio Cinieri	2.5k 1.4×	1.0k 0.9×	957 1.1×	930 1.3×	535 1.1×	206	4.3k
Paul Cottu	2.5k 1.4×	1.3k 1.1×	1.8k 2.1×	1.1k 1.5×	981 1.9×	233	5.1k
Nicolaì Maass	1.8k 1.1×	1.3k 1.2×	1.1k 1.3×	773 1.1×	253 0.5×	274	4.9k
Teresa A. Goldin	1.9k 1.1×	2.1k 1.8×	1.3k 1.4×	1.2k 1.7×	341 0.7×	5	4.7k
Andrew Kramar	1.9k 1.1×	1.1k 0.9×	809 0.9×	1.1k 1.5×	427 0.8×	102	4.6k
Stephen A. Cannistra	1.9k 1.1×	2.0k 1.8×	756 0.9×	512 0.7×	622 1.2×	46	5.1k
Madappa N. Kundranda	2.4k 1.4×	2.5k 2.2×	1.5k 1.7×	1.4k 1.9×	421 0.8×	66	5.8k

Countries citing papers authored by Flora Zagouri

Since Specialization

Citations

This map shows the geographic impact of Flora Zagouri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flora Zagouri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flora Zagouri more than expected).

Fields of papers citing papers by Flora Zagouri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flora Zagouri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flora Zagouri. The network helps show where Flora Zagouri may publish in the future.

Co-authorship network of co-authors of Flora Zagouri

This figure shows the co-authorship network connecting the top 25 collaborators of Flora Zagouri. A scholar is included among the top collaborators of Flora Zagouri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flora Zagouri. Flora Zagouri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liontos, Michalis, Dimitrios Haidopoulos, Flora Zagouri, et al.. (2025). Epigenetics in Ovarian Cancer: A Review of Current Knowledge and Future Perspectives. Biomedicines. 13(11). 2820–2820. 1 indexed citations

Majem, Margarita, Vanesa Gregorc, Giuseppe Lo Russo, et al.. (2025). LBA1: First-line (1L) fulzerasib + cetuximab in KRAS G12Cm advanced NSCLC: Updated efficacy and safety from KROCUS study. Journal of Thoracic Oncology. 20(3). S1–S1.

Westin, Shannon N., Kathleen N. Moore, Hye Sook Chon, et al.. (2025). Durvalumab Plus Carboplatin/Paclitaxel Followed By Durvalumab With/Without Olaparib In Endometrial Cancer: Exploratory Analyses Of Histology, Biomarker Heterogeneity And Efficacy In The DUO-E Mismatch Repair Proficient Subpopulation. International Journal of Gynecological Cancer. 35(2). 101703–101703.

Fountzilas, Elena, Anna Koumarianou, Davide Mauri, et al.. (2024). Real-world data on the safety and efficacy of trastuzumab deruxtecan and sacituzumab govitecan in patients with advanced breast cancer: the experience of the Hellenic Cooperative Oncology Group. European Journal of Cancer. 200. 113954–113954.

Agarwal, Neeraj, James Brugarolas, Pooja Ghatalia, et al.. (2024). Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma. Annals of Oncology. 35(12). 1148–1156. 6 indexed citations

Ueno, Naoto T., Filipa Cardoso, Toshinari Yamashita, et al.. (2024). 188P A health-related quality-of-life (HRQoL) analysis from DESTINY-Breast04: Trastuzumab deruxtecan (T-DXd) vs capecitabine (CAP) in patients (Pts) with hormone receptor-positive (HR+), HER2-low metastatic breast cancer (mBC). ESMO Open. 9. 103210–103210. 2 indexed citations

O’Malley, David M., Bradley Monk, Myong Cheol Lim, et al.. (2024). Final safety results from ATHENA–MONO (GOG-3020/ENGOT-ov45), a randomized, placebo-controlled, double-blind, phase 3 trial evaluating rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer.. Journal of Clinical Oncology. 42(16_suppl). 5554–5554. 4 indexed citations

Liontos, Michalis, Evangelos Bournakis, Vassiliki Zolota, et al.. (2024). Real-World Treatment Patterns in Patients With Metastatic Castration-Resistant Prostate Cancer in Greece: The PROSPECT Study. Clinical Genitourinary Cancer. 22(6). 102170–102170.

Brugarolas, James, Pooja Ghatalia, S. George, et al.. (2023). 1881O Safety and efficacy of two doses of belzutifan in patients (pts) with advanced RCC: Results of the randomized phase II LITESPARK-013 study. Annals of Oncology. 34. S1011–S1011. 4 indexed citations

10.

Liontos, Michalis, Αριστέα-Μαρία Παπανώτα, Vasilios Pergialiotis, et al.. (2023). Immunohistochemical expression of ER and p53 as predictive biomarkers of immunotherapy in endometrial cancer.. Journal of Clinical Oncology. 41(16_suppl). e17626–e17626.

11.

Andrikopoulou, Αngeliki, et al.. (2022). The Mutational Landscape of Early-Onset Breast Cancer: A Next-Generation Sequencing Analysis. Frontiers in Oncology. 11. 797505–797505. 6 indexed citations

12.

Tsakogiannis, D., Marios Nikolaidis, Flora Zagouri, et al.. (2022). Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas. Viruses. 15(1). 141–141. 9 indexed citations

13.

Veroutis, Dimitris, Flora Zagouri, George Galyfos, et al.. (2020). Carotid Disease and Ageing: A Literature Review on the Pathogenesis of Vascular Senescence in Older Subjects. Current Gerontology and Geriatrics Research. 2020. 1–10. 12 indexed citations

14.

Zagouri, Flora, Émilie Le Rhun, Rupert Bartsch, et al.. (2020). Intrathecal administration of anti-HER2 treatment for the treatment of meningeal carcinomatosis in breast cancer: A metanalysis with meta-regression. Cancer Treatment Reviews. 88. 102046–102046. 45 indexed citations

15.

Dimitrakakis, Constantine, Flora Zagouri, Spyridon S Marinopoulos, et al.. (2019). Paving the way for changing perceptions in breast surgery: a systematic literature review focused on oncological and aesthetic outcomes of oncoplastic surgery for breast cancer. Breast Cancer. 26(4). 416–427. 12 indexed citations

16.

Tsiatas, Marinos, Konstantine T. Kalogeras, Kyriaki Manousou, et al.. (2018). Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early‐stage breast cancer patients treated with anthracycline‐based adjuvant chemotherapy. Cancer Medicine. 7(10). 5066–5082. 8 indexed citations

17.

Koutoulidis, Vassilis, Evangelos Terpos, Ioannis Ntanasis‐Stathopoulos, et al.. (2017). Diffuse Medullary Hyperdensities of the Femora and Humeri on Whole-Body Low-Dose Computed Tomography Identify Diffuse MRI Pattern of Involvement and Correlate with Advanced Disease Stage in Patients with Multiple Myeloma. Blood. 130. 4404–4404. 1 indexed citations

18.

Koutras, Αngelos, Konstantine T. Kalogeras, Ralph M. Wirtz, et al.. (2015). Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study. Journal of Translational Medicine. 13(1). 171–171. 12 indexed citations

19.

Zagouri, Flora, et al.. (2010). Molecular markers in epithelial ovarian cancer: their role in prognosis and therapy.. PubMed. 31(3). 268–77. 16 indexed citations

20.

Zagouri, Flora, George Bozas, Marinos Tsiatas, et al.. (2010). Endometrial Cancer: What Is New in Adjuvant and Molecularly Targeted Therapy?. Obstetrics and Gynecology International. 2010(1). 749579–749579. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact